| Nomenclature for antiviral resistant human hepatitis B virus mutations in the polymerase region LJ Stuyver, SA Locarnini, A Lok, DD Richman, WF Carman, JL Dienstag, ... Frontiers in Viral Hepatitis, 335-351, 2003 | 594 | 2003 |
| The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance SK Ono, N Kato, Y Shiratori, J Kato, T Goto, RF Schinazi, FJ Carrilho, ... The Journal of clinical investigation 107 (4), 449-455, 2001 | 416 | 2001 |
| Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer N Kato, H Yoshida, SK Ono-Nita, J Kato, T Goto, M Otsuka, K Lan, ... Hepatology 32 (2), 405-412, 2000 | 347 | 2000 |
| YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull‐length viral DNA transfection SK Ono‐Nita, N Kato, Y Shiratori, T Masaki, KH Lan, FJ Carrilho, M Omata Hepatology 29 (3), 939-945, 1999 | 251 | 1999 |
| Hepatitis C Virus Nonstructural Region 5A Protein: A Potent Transcriptional Activator N Kato, KH Lan, SK Ono-Nita, H Yoshida, Y Shiratori, M Omata HCV and Related Liver Diseases, 45-58, 1999 | 209 | 1999 |
| Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors SK Ono-Nita, N Kato, Y Shiratori, KH Lan, H Yoshida, FJ Carrilho, ... The Journal of clinical investigation 103 (12), 1635-1640, 1999 | 193 | 1999 |
| Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo J Kato, N Kato, H Yoshida, SK Ono‐Nita, Y Shiratori, M Omata Journal of medical virology 66 (2), 187-199, 2002 | 119 | 2002 |
| Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide ND Shah, M Ventura-Cots, JG Abraldes, M Alboraie, A Alfadhli, J Argemi, ... Clinical Gastroenterology and Hepatology 17 (11), 2320-2329. e12, 2019 | 107 | 2019 |
| Avaliação de tecnologia em saúde: II. A análise de custo-efetividade SR Secoli, ME Nita, SK Ono-Nita, M Nobre Arquivos de Gastroenterologia 47, 329-333, 2010 | 98* | 2010 |
| Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Y Shiratori, S Shiina, PY Zhang, E Ohno, T Okudaira, DA Payawal, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1997 | 93 | 1997 |
| Avaliação de tecnologias em saúde: evidência clínica, análise econômica e análise de decisão ME Nita, SR Secoli, MRC Nobre, SK Ono-Nita, ACC Campino, FM Sarti, ... Avaliação de tecnologias em saúde: evidência clínica, análise econômica e …, 2010 | 90 | 2010 |
| Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort DC Paranaguá-Vezozzo, SK Ono, MV Alvarado-Mora, AQ Farias, ... Annals of hepatology 13 (4), 386-393, 2014 | 87 | 2014 |
| Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus SK Ono-Nita, N Kato, Y Shiratori, FJ Carrilho, M Omata Antimicrobial Agents and Chemotherapy 46 (8), 2602-2605, 2002 | 76 | 2002 |
| Pegylated interferon alfa for chronic hepatitis B: systematic review and meta‐analysis V Kim, RM Abreu, DM Nakagawa, RM Baldassare, FJ Carrilho, SK Ono Journal of Viral Hepatitis 23 (3), 154-169, 2016 | 59 | 2016 |
| Molecular aspects of hepatic carcinogenesis NM Eidi, AVA Ferreira, ONONS CARRILHO Flair José, MES Kioko, ... Revista do Instituto de Medicina Tropical de São Paulo 44, 2002 | 55 | 2002 |
| 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients JA Nogueira, SK Ono-Nita, ME Nita, MMT de Souza, EP do Carmo, ... BMC cancer 9, 1-8, 2009 | 53 | 2009 |
| Bcl‐XL Antisense Sensitizes Human Colon Cancer Cell Line to 5‐Fluorouracil ME Nita, SK Ono‐Nita, N Tsuno, O Tominaga, T Takenoue, E Sunami, ... Japanese journal of cancer research 91 (8), 825-832, 2000 | 50 | 2000 |
| 52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B T Piratvisuth, P Komolmit, T Tanwandee, W Sukeepaisarnjaroen, ... PloS one 8 (2), e54279, 2013 | 41 | 2013 |
| Métodos de pesquisa em avaliação de tecnologia em saúde ME Nita, SR Secoli, M Nobre, SK Ono-Nita Arquivos de Gastroenterologia 46, 252-255, 2009 | 41* | 2009 |
| Large isoform of hepatitis delta antigen activates serum response factor-associated transcription T Goto, N Kato, SK Ono-Nita, H Yoshida, M Otsuka, Y Shiratori, M Omata Journal of Biological Chemistry 275 (48), 37311-37316, 2000 | 40 | 2000 |
